Pro Tip: Learn how to use HBI Alerts to follow your favorite topics

Medtech

 

Interview: Phil Frame, NorthEdge

NorthEdge is a regionally focussed UK PE firm, headquartered in Manchester and with presence across the North and Midlands. It invests in lower mid-market companies across the healthcare, technology and business services sectors, and currently has £900m of assets under management.  In an interview with HBI, Phil Frame, Partner and Healthcare Investment Lead at NorthEdge, discussed some of the areas of healthcare innovation the firm is currently most excited about, and the abundant opportunity in the UK regions.

Interview: Dr Oliver Harrison, Koa Health

Dr Oliver Harrison is the founder and chief executive of Koa Health, a UK-headquartered digital mental health company. He spoke to us about what makes Koa Health different and about the company’s new employer-funded mental health platform which he describes as the culmination of the work the company has been doing to date.

Addressing healthcare workforce inefficiency through AI and 3d indoor mapping – a conversation with Connie Moser of Navenio

Modern hospitals are incredibly complex, regularly chaotic, and often inefficient environments, despite efficiency and proper task sequencing being vital to delivering high-quality medical care and positive patient experiences. Workforce issues are beginning to bite harder across both public and private provider systems, driven by a growing deficit in medical professionals serving an expanding patient population. […]

CVC Capital acquires major stake in Indonesia’s Siloam Hospitals, signalling rising PE interest in Southeast Asia healthcare

CVC Capital Partners, a Luxembourg-based private equity firm, has acquired an additional 45% stake in Indonesia's chain of multi speciality hospitals, Siloam Hospitals, from the country’s conglomerate Lippo Karawaci for 16.6 trillion rupiah ($1 billion), making CVC the majority shareholder. This transaction, involving 5.85 billion shares, was announced on the Indonesia Stock Exchange.

What innovations are health tech investors most excited about in 2024?

Healthcare is a sector in which it can be hard to innovate. Regulations are tight and risk aversion is rife. This is understandable — justifiable, even — given lives are at stake. But it means the sector doesn’t see much creative destruction in the models it uses for delivering care. 

Exploring ‘dark labs’, at-home testing potential, and the diagnostic lab sector’s consolidation at HBI 2024

The global laboratory diagnostics market has grown significantly, with research estimating its value at around USD $210.58 billion in 2023. It is expected to reach approximately USD $284.38 billion by 2033, expanding at a CAGR of 3.05% from 2024 to 2033. This growth is driven by rising chronic diseases, an ageing population, and the increasing demand for early diagnostics. At HBI 2024, the panel 'Laboratory Diagnostics – Growth Beyond Consolidation' brought together industry experts.

Find Us